The treatment effects by combinative supplementation of formoterol, indomethacin and roxithromycin on cancer cachexia mice
- VernacularTitle:三种药物联合治疗癌症恶病质的实验研究
- Author:
Sizeng CHEN
;
Lixiang ZHAO
- Publication Type:Journal Article
- Keywords:
Cancer cachexia;
Formoterol;
Indomethacin;
Roxithromycin;
Combination therapy
- From:
Parenteral & Enteral Nutrition
2010;17(2):98-100,105
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To observe the effect of the combinative supplementation of Formoterol, Indomethacin and Roxithromycin on cancer cachexia (CC) and to study the mechanism. Methods: Male BALB/c mice bearing colon 26 adenocarcinoma for 9 days were served as models of cancer cachexia. The mice were divided into nine groups. Physiological conditions, body weight and food intake were documented every day. Serum levels of cytokine and nutritional markers were detected 7 days after treatment. Results: Tumor-bearing caused a wasting of non-tumor body weight and gastrocnemius muscle. Serum tumor necrosis factor-α, (TNF-α) and interleukin-6 (IL-6) levels were significantly elevated accompanied with nutrition depletion in tumor-bearing mice. After treatment with combinative supplementation of Formoterol, Indomethacin and Roxithromycin, left gastrocnemius weight and serum glucose were improved and the levels of TNF-α and triglyceride were down-regulated. Conclusion: Formoterol, Indomethacin and Roxithromycin had their own positive effects to CC mice. Drugs combinationin in tumor-bearing mice with cancer cachexia could produce synergistic action.
